Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Ardelyx, Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases.
IPO Date: June 19, 2014
Sector: Healthcare
Industry: Biotech
Market Cap: $875.67M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.23 | 3.26%
Avg Daily Range (30 D): $0.11 | 2.96%
Avg Daily Range (90 D): $0.13 | 2.89%
Institutional Daily Volume
Avg Daily Volume: 2.36M
Avg Daily Volume (30 D): 4.5M
Avg Daily Volume (90 D): 4.49M
Trade Size
Avg Trade Size (Sh.): 273
Avg Trade Size (Sh.) (30 D): 229
Avg Trade Size (Sh.) (90 D): 206
Institutional Trades
Total Inst.Trades: 1,379
Avg Inst. Trade: $2.22M
Avg Inst. Trade (30 D): $1.43M
Avg Inst. Trade (90 D): $1.82M
Avg Inst. Trade Volume: .44M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.01M
Avg Closing Trade (30 D): $1.66M
Avg Closing Trade (90 D): $2.01M
Avg Closing Volume: 563.54K
   
News
Jun 2, 2025 @ 5:50 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: N/A
May 21, 2025 @ 12:00 PM
Ardelyx to Participate at the Jefferies Global Hea...
Source: N/A
Apr 24, 2025 @ 12:01 PM
Ardelyx Announces Three Abstracts Accepted for Pos...
Source: N/A
Feb 19, 2025 @ 1:01 PM
Ardelyx to Present at the TD Cowen 45th Annual Hea...
Source: Ardelyx, Inc.
Jan 6, 2025 @ 1:00 PM
Ardelyx to Present at the 43rd Annual J.P. Morgan ...
Source: N/A
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.22 $-.17 $.02
Diluted EPS $-.22 $-.17 $.02
Revenue $ 361.71M $ 74.11M $ 116.13M
Gross Profit $ 305.98M $ 61.81M $ 97.87M
Net Income / Loss $ -53.76M $ -41.14M $ 4.65M
Operating Income / Loss $ -39.62M $ -36.35M $ 8.13M
Cost of Revenue $ 55.73M $ 12.3M $ 18.26M
Net Cash Flow $ -5.34M $ -34.12M $ 17.5M
PE Ratio